Skip to content
MPN Advocates Network
  • MPN Horizons
    • MPN Horizons Virtual Conference 2021: Learn. Share. Grow.
    • MPN Horizons 2021
    • MPN Horizons 2020 – Day 1
    • MPN Horizons 2020 – Day 2
    • MPN Horizons 2019
    • MPN Horizons 2018
    • MPN Horizons 2017
    • MPN Horizons 2016
  • About
  • Goal
  • Members
    • Members
    • Forum
  • In the News
  • Events
  • Info
    • What are MPN’s
    • Prevalence
    • Clinical trials
  • Contact

Inrebic, a new inhibitor drug for PMF, was approved by the EMA

13 January 2021 By Natasa Hace Comment Closed

Inrebic (fedratinib), a new inhibitor drug, received a positive opinion for the treatment of primary myelofibrosis and of myelofibrosis secondary to polycythaemia vera or essential thrombocythaemia by the European Medicines Agency’s (EMA) Human Medicines Committee (CHMP) at its December 2020 meeting.
Please read more: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/inrebic

Geen categorie, In the News
Home
  • #WeStandWithUkraine
  • Announcing three new Steering Committee Members!
  • Call for Abstracts
  • Featured
  • Forum
  • Home
  • Human Medicines Highlights Newsletter
  • Join us TODAY for the 6th MPN Horizons Conference!
  • MPN AN announces the retirement of Peter Loffelhardt and Robi Zelig
  • MPN AN announces three new Steering Committee members
  • MPN Awareness Day 2021
  • MPN Horizons 2019 – Session Slides and Videos
  • MPN Horizons 2020
  • MPN Horizons 2020: Day 2
  • MPN Horizons 2021 – Registration is NOW OPEN!
    • Call for Posters
  • MPN Horizons 2021 Virtual Conference
  • MPN Horizons Virtual Conference 2021: Learn. Share. Grow.
  • MPN news from ASH 2020
  • MPN News from ASH 2021
  • My Account
  • Part One of MPN Horizons 2020 a success; Day Two on 24 January 2021!
  • REGISTER NOW FOR 2020 MPN Horizons
  • Registration
  • Registration for MPN Advocates Forum
  • SandBox
  • Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis
  • Video is now available of our recent MPN AN webinar
Contact
  • #WeStandWithUkraine
  • Announcing three new Steering Committee Members!
  • Call for Abstracts
  • Contact
  • Featured
  • Forum
  • Human Medicines Highlights Newsletter
  • Join us TODAY for the 6th MPN Horizons Conference!
  • MPN AN announces the retirement of Peter Loffelhardt and Robi Zelig
  • MPN AN announces three new Steering Committee members
  • MPN Awareness Day 2021
  • MPN Horizons 2019 – Session Slides and Videos
  • MPN Horizons 2020
  • MPN Horizons 2020: Day 2
  • MPN Horizons 2021 – Registration is NOW OPEN!
    • Call for Posters
  • MPN Horizons 2021 Virtual Conference
  • MPN Horizons Virtual Conference 2021: Learn. Share. Grow.
  • MPN news from ASH 2020
  • MPN News from ASH 2021
  • My Account
  • Part One of MPN Horizons 2020 a success; Day Two on 24 January 2021!
  • REGISTER NOW FOR 2020 MPN Horizons
  • Registration
  • Registration for MPN Advocates Forum
  • SandBox
  • Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis
  • Video is now available of our recent MPN AN webinar
About Us
  • #WeStandWithUkraine
  • About us
  • Announcing three new Steering Committee Members!
  • Call for Abstracts
  • Featured
  • Forum
  • Human Medicines Highlights Newsletter
  • Join us TODAY for the 6th MPN Horizons Conference!
  • MPN AN announces the retirement of Peter Loffelhardt and Robi Zelig
  • MPN AN announces three new Steering Committee members
  • MPN Awareness Day 2021
  • MPN Horizons 2019 – Session Slides and Videos
  • MPN Horizons 2020
  • MPN Horizons 2020: Day 2
  • MPN Horizons 2021 – Registration is NOW OPEN!
    • Call for Posters
  • MPN Horizons 2021 Virtual Conference
  • MPN Horizons Virtual Conference 2021: Learn. Share. Grow.
  • MPN news from ASH 2020
  • MPN News from ASH 2021
  • My Account
  • Part One of MPN Horizons 2020 a success; Day Two on 24 January 2021!
  • REGISTER NOW FOR 2020 MPN Horizons
  • Registration
  • Registration for MPN Advocates Forum
  • SandBox
  • Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis
  • Video is now available of our recent MPN AN webinar
Search
WordPress Theme | Square by HashThemes